Additive manufacturing of embedded materials

Patent metadata

Field	Value
Publication number	US-12433973-B2
Application number	US-202318142503-A
Country	US
Kind code	B2
Filing date	May 2, 2023
Priority date	Jul 29, 2013
Publication date	Oct 7, 2025
Grant date	Oct 7, 2025

Abstract

In one aspect, a method includes providing support material within which the structure is fabricated, depositing, into the support material, structure material to form the fabricated structure, and removing the support material to release the fabricated structure from the support material. The provided support material is stationary at an applied stress level below a threshold stress level and flows at an applied stress level at or above the threshold stress level during fabrication of the structure. The provided support material is configured to mechanically support at least a portion of the structure and to prevent deformation of the structure during the fabrication of the structure. The deposited structure material is suspended in the support material at a location where the structure material is deposited. The structure material comprises a fluid that transitions to a solid or semi-solid state after deposition of the structure material.

First claim

What is claimed is:

1. A system that is configured for fabricating a structure, the system comprising:
a structure material that is configured to form the structure; and
a support material comprising a plurality of gel microparticles, wherein the support material is configured to transition from behaving as a fluid to behaving as a solid or semi-solid state at a location where the structure material is deposited in the support material to form the structure, the behavior transition being in response to an application to the support material of a shear stress above a threshold shear stress, the behavior transition being a fluid state behavior above the threshold shear stress and a solid state or semi-solid state behavior at and below the threshold shear stress during the depositing of the structure material in the support material, wherein the structure material is configured to apply the shear stress at the location above the threshold shear stress when the structure material is deposited into the support material.

2. The system of claim 1 , wherein the structure material comprises a tissue scaffold for supporting a plurality of cells, the structure material being incubated to form a tissue from the plurality of cells supported by the tissue scaffold after deposition of the structure material into the support material.

3. The system of claim 1 , wherein the support material comprises at least one of an albumin-foam, a gelatin slurry, a poly(N-isopropylacrylamide) (PNIPAAM) slurry, a polyacrylate slurry, an Agarose material, and an alginate slurry.

4. The system of claim 1 , wherein the structure material comprises a bioactive molecule configured to bind a plurality of cells.

5. The system of claim 4 , wherein the bioactive molecule comprises a cell-adhesive polypeptide.

6. The system of claim 1 , wherein the structure material comprises a tissue scaffold for supporting a plurality of cells, and wherein the tissue scaffold comprises at least one of a collagen material, an alginate material, and a fibrinogen material.

7. The system of claim 1 , wherein the structure comprises a perfusable vascular structure.

8. The system of claim 1 , further comprising a syringe-based extruder that is insertable into the support material and configured to extrude the structure material into the support material to cause the support material to locally transition from behaving as the solid state or semi-solid state to behaving as the fluid state, wherein the support material is configured to prevent deflection of the syringe-based extruder during deposition into the support material.

9. The system of claim 1 , wherein the support material comprises a crosslinking agent for treating the structure material to cause the structure material to transition from a fluid to a solid or semi-solid state after deposition of the structure material in the support material.

10. The system of claim 9 , wherein the crosslinking agent comprises at least one of calcium chloride or thrombin.

11. The system of claim 1 , wherein the support material comprises a material having a different pH from the structure material to cause the structure material to transition from a fluid to a solid or semi-solid state after deposition of the structure material in the support material.

12. The system of claim 1 , wherein the support material comprises a sterile, buffered, aqueous environment.

13. The system of claim 1 , wherein the structure comprises a plurality of muscle fiber threads configured to form a muscle architecture, the muscle architecture comprising one of a parallel muscle architecture or a convergent muscle architecture.

14. The system of claim 1 , wherein the structure comprises at least one of silver nanoparticles and silica nanoparticles.

15. The system of claim 1 , wherein the structure comprises at least one of a carbon fiber reinforced epoxy, a ceramic, a clay, a metallic colloid, a resin, a silicone, and a thermoplastic.

16. The system of claim 1 , wherein the structure comprises at least one of a protein, a polysaccharide hydrogel, a synthetic hydrogel, and a rigid polymer comprising one of polydimethylsiloxane (PDMS), polyurethane, a thermoset, a coacervate solids, or a foam.

17. The system of claim 1 , wherein the structure material is configured to cease applying the shear stress at the location above the threshold shear stress after deposition of the structure material into the support material.

Assignees

• Univ Carnegie Mellon

Inventors

• Feinberg Adam
• Hinton Thomas

Classifications

• B29L2031/7532

  Artificial members, protheses · CPC title

• B29K2089/00

  Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material · CPC title

• B29K2005/00

  Use of polysaccharides or derivatives as moulding material · CPC title

• A61L27/24

  Collagen · CPC title

• A61L27/227

  Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24 · CPC title